HKSE - Delayed Quote HKD

MicroPort CardioFlow Medtech Corporation (2160.HK)

Compare
0.700 -0.020 (-2.78%)
At close: 3:54 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
336,215.000
336,215.000
251,026.000
200,813.000
103,934.000
Cost of Revenue
106,284.000
106,284.000
88,896.000
82,112.000
58,554.000
Gross Profit
229,931.000
229,931.000
162,130.000
118,701.000
45,380.000
Operating Expense
581,571.000
581,571.000
494,008.000
321,904.000
230,753.000
Operating Income
-351,640.000
-351,640.000
-331,878.000
-203,203.000
-185,373.000
Net Non Operating Interest Income Expense
82,397.000
82,397.000
33,231.000
4,810.000
-141,083.000
Pretax Income
-463,582.000
-463,582.000
-451,299.000
-182,651.000
-398,087.000
Tax Provision
7,952.000
7,952.000
3,096.000
613.000
--
Net Income Common Stockholders
-471,534.000
-471,534.000
-454,395.000
-183,264.000
-398,087.000
Diluted NI Available to Com Stockholders
-471,534.000
-471,534.000
-454,395.000
-183,264.000
-398,087.000
Basic EPS
-0.20
-0.20
-0.19
-0.08
-0.17
Diluted EPS
-0.20
-0.20
-0.19
-0.08
-0.17
Basic Average Shares
2,362,906.000
2,362,906.000
2,365,637.000
2,331,301.000
2,366,167.020
Diluted Average Shares
2,362,906.000
2,362,906.000
2,365,637.000
2,331,301.000
2,366,167.020
Total Operating Income as Reported
-313,651.000
-313,651.000
-376,579.000
-159,238.000
-252,496.000
Total Expenses
687,855.000
687,855.000
582,904.000
404,016.000
289,307.000
Net Income from Continuing & Discontinued Operation
-471,534.000
-471,534.000
-454,395.000
-183,264.000
-398,087.000
Normalized Income
-372,951.750
-372,951.750
-390,840.750
-200,401.500
-333,344.000
Interest Income
86,544.000
86,544.000
38,642.000
24,711.000
5,224.000
Interest Expense
3,915.000
3,915.000
5,188.000
19,639.000
146,150.000
Net Interest Income
82,397.000
82,397.000
33,231.000
4,810.000
-141,083.000
EBIT
-459,667.000
-459,667.000
-446,111.000
-163,012.000
-251,937.000
EBITDA
-386,049.000
-386,049.000
-367,896.000
-118,589.000
-227,434.000
Reconciled Cost of Revenue
106,284.000
106,284.000
88,896.000
82,112.000
58,554.000
Reconciled Depreciation
73,618.000
73,618.000
78,215.000
44,423.000
24,503.000
Net Income from Continuing Operation Net Minority Interest
-471,534.000
-471,534.000
-454,395.000
-183,264.000
-398,087.000
Total Unusual Items Excluding Goodwill
-131,443.000
-131,443.000
-84,739.000
22,850.000
-64,743.000
Total Unusual Items
-131,443.000
-131,443.000
-84,739.000
22,850.000
-64,743.000
Normalized EBITDA
-254,606.000
-254,606.000
-283,157.000
-141,439.000
-162,691.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
--
Tax Effect of Unusual Items
-32,860.750
-32,860.750
-21,184.750
5,712.500
--
12/31/2020 - 2/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers